Lyell acquires worldwide rights from ICT to CAR T-cell therapy
Lyell Immunopharma has acquired exclusive worldwide rights from Innovative Cellular Therapeutics (ICT) to LYL273, an advanced chimeric antigen receptor (CAR)…
All articles by
-
-
Novartis opens California site for RLT manufacturing
Novartis has opened a 10,000ft² radioligand therapy (RLT) manufacturing facility in Carlsbad in the US state of California, as part…
-
Harbour BioMed and Evinova collaborate on AI biologics
Harbour BioMed and Evinova China have formed a collaboration to implement AI and digital technologies to improve biologics development. The…
-
SanegeneBio and Lilly sign RNAi licence deal for metabolic diseases
SanegeneBio has formed a worldwide research and licensing partnership with Eli Lilly and Company to develop RNAi [RNA interference] candidates…
-
Abzena and Mabqi partner for drug development solution
Abzena and Mabqi have announced a partnership integrating antibody discovery capabilities with development and manufacturing services for a drug development…
-
Alvotech and Advanz announce MHRA marketing authorisations for Gobivaz
Alvotech and Advanz Pharma have announced the receipt of marketing authorisations from the UK Medicines and Healthcare products Regulatory Agency…
-
Cencora to invest $1bn in US pharma distribution network
Cencora is set to invest $1bn by 2030 for expanding its US pharmaceutical distribution network, adding resilience and capacity to…
-
Leukogene Therapeutics gains FDA ODD status for M2T-CD33
Leukogene Therapeutics has received orphan drug designation (ODD) from the US Food and Drug Administration (FDA) for M2T-CD33 (LTI-214), its…
-
Avant and SGAustria form JV to develop diabetes therapy
Avant Technologies and SGAustria have announced a joint venture (JV) and licence agreement to advance a therapy for diabetes using…
-
AmacaThera and Pacira sign agreement for AMT-143
AmacaThera has entered into an exclusive worldwide licensing agreement with Pacira BioSciences for up to $230m for AMT-143, an investigational…